HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thorsten Wahlers Selected Research

Celsior

1/2008Exogenous surfactant application in a rat lung ischemia reperfusion injury model: effects on edema formation and alveolar type II cells.
8/2005Experimental lung transplantation: impact of preservation solution and route of delivery.
6/2005Improved lung preservation relates to an increase in tubular myelin-associated surfactant protein A.
9/2003Reduced vascular endothelial growth factor correlates with alveolar epithelial damage after experimental ischemia and reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thorsten Wahlers Research Topics

Disease

17Heart Failure
05/2022 - 11/2005
15Cardiogenic Shock
06/2022 - 05/2013
14Atrial Fibrillation
01/2022 - 07/2009
14Ischemia
01/2021 - 03/2003
14Reperfusion Injury
07/2015 - 06/2003
13Myocardial Infarction
01/2022 - 09/2011
12Stroke (Strokes)
07/2022 - 06/2008
12Edema (Dropsy)
03/2013 - 06/2003
10Renal Insufficiency (Renal Failure)
05/2021 - 06/2008
10Inflammation (Inflammations)
12/2019 - 02/2003
8Endocarditis
10/2022 - 03/2005
8Coronary Artery Disease (Coronary Atherosclerosis)
06/2021 - 12/2002
7Neoplasms (Cancer)
09/2022 - 10/2004
7Wounds and Injuries (Trauma)
10/2021 - 11/2003
7Primary Graft Dysfunction
04/2019 - 06/2011
6Neoplasm Metastasis (Metastasis)
08/2022 - 10/2004
6Hemorrhage
01/2022 - 08/2006
6Infections
01/2020 - 05/2007
6Thrombosis (Thrombus)
01/2018 - 04/2004
5Heart Arrest (Cardiac Arrest)
03/2022 - 05/2014
5Acute Kidney Injury (Acute Renal Failure)
10/2021 - 09/2015
5Acute Coronary Syndrome
01/2021 - 01/2018
5Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 04/2009
5Bronchiolitis Obliterans Syndrome
01/2016 - 02/2006
4Aortic Valve Stenosis (Aortic Stenosis)
05/2022 - 01/2012
4Out-of-Hospital Cardiac Arrest
03/2022 - 02/2021
4Rupture
01/2022 - 09/2003
4Hypoxia (Hypoxemia)
01/2021 - 05/2007
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2017 - 09/2009
3Cardiomyopathies (Cardiomyopathy)
03/2022 - 08/2021
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
03/2022 - 12/2013
3ST Elevation Myocardial Infarction
12/2020 - 01/2017
3Lung Diseases (Lung Disease)
01/2016 - 10/2005
3Chronic Obstructive Pulmonary Disease (COPD)
12/2015 - 07/2012
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2015 - 05/2007
3Pathologic Constriction (Stenosis)
12/2013 - 11/2003
3Acute Lung Injury
01/2008 - 09/2003
2Congenital Heart Defects (Congenital Heart Defect)
03/2021 - 04/2019
2Pulmonary Embolism
01/2021 - 07/2020
2Aortic Dissection
01/2021 - 11/2018
2Aortic Valve Insufficiency (Aortic Regurgitation)
01/2021 - 08/2020
2Hypertrophy
01/2021 - 01/2019
2Shock
10/2019 - 04/2019
2Diabetes Mellitus
01/2019 - 07/2012
2Sepsis (Septicemia)
11/2018 - 08/2013
2Respiratory Insufficiency (Respiratory Failure)
10/2017 - 08/2013
2Aneurysm (Aneurysms)
02/2016 - 09/2003
2Body Weight (Weight, Body)
05/2014 - 01/2008
2Wound Infection (Wound Infections)
08/2013 - 03/2013
2Pulmonary Hypertension
09/2011 - 07/2002
2Pulmonary Edema
11/2009 - 01/2008

Drug/Important Bio-Agent (IBA)

10Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 06/2008
8Surface-Active Agents (Surfactants)IBA
09/2014 - 06/2005
6salicylhydroxamic acid (SHAM)IBA
01/2019 - 04/2004
5PerfadexIBA
05/2007 - 06/2003
4CelsiorIBA
01/2008 - 09/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2003
3Interleukin-6 (Interleukin 6)IBA
01/2019 - 05/2012
3CreatinineIBA
11/2018 - 09/2011
3SolutionsIBA
05/2007 - 09/2003
3Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2005 - 07/2002
21,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA
01/2020 - 01/2018
2Cell-Free Nucleic AcidsIBA
12/2019 - 01/2019
2CatecholaminesIBA
10/2019 - 04/2019
2Prostaglandins DIBA
04/2019 - 06/2016
2Indicators and Reagents (Reagents)IBA
12/2018 - 09/2003
2omega-Chloroacetophenone (Mace)IBA
01/2018 - 01/2015
2EnzymesIBA
01/2016 - 04/2015
2poractant alfa (Curosurf)FDA Link
03/2013 - 01/2012
2C-Reactive ProteinIBA
07/2010 - 01/2004
2Dihydrotachysterol (AT 10)IBA
09/2009 - 09/2003
2Sirolimus (Rapamycin)FDA Link
03/2009 - 02/2006
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2006 - 01/2004

Therapy/Procedure

33Therapeutics
11/2022 - 05/2007
22Extracorporeal Membrane Oxygenation
06/2022 - 05/2007
17Lung Transplantation
04/2019 - 09/2003
16Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 12/2002
13Heart-Assist Devices
03/2022 - 12/2013
10Transcatheter Aortic Valve Replacement
05/2022 - 01/2012
10Cardiopulmonary Bypass (Heart-Lung Bypass)
10/2020 - 11/2009
8Length of Stay
09/2022 - 03/2013
7Cardiopulmonary Resuscitation (CPR)
01/2022 - 04/2019
5Transplantation
01/2021 - 05/2014
5Percutaneous Coronary Intervention
01/2021 - 04/2009
4Metastasectomy
11/2022 - 06/2017
4Renal Dialysis (Hemodialysis)
03/2022 - 03/2009
4Sternotomy
01/2022 - 09/2003
4Sutures (Suture)
06/2019 - 08/2006
4Stents
07/2017 - 02/2003
3Neoadjuvant Therapy
08/2022 - 10/2004
3Myocardial Revascularization
07/2022 - 01/2019
3Prostheses and Implants (Prosthesis)
09/2021 - 03/2003
3Resuscitation
01/2021 - 01/2017
3Organ Transplantation
01/2016 - 07/2002
3Secondary Prevention
08/2015 - 01/2004
2Blood Transfusion (Blood Transfusions)
03/2022 - 12/2018
2Contraindications
01/2021 - 06/2016
2Hemofiltration
11/2018 - 12/2015
2Perioperative Care
08/2015 - 04/2012
2Heart Transplantation (Grafting, Heart)
03/2009 - 02/2008